Your browser doesn't support javascript.
loading
Application of CRISPR/Cas9 System to Reverse ABC-Mediated Multidrug Resistance.
Wang, Wei; Liang, Ze; Ma, Pengfei; Zhao, Qi; Dai, Mengyuan; Zhu, Jie; Han, Xu; Xu, Hong; Chang, Qingyan; Zhen, Yuhong.
Afiliação
  • Wang W; College of Pharmacy, Dalian Medical University, Dalian, 116044, China.
  • Liang Z; College of Pharmacy, Dalian Medical University, Dalian, 116044, China.
  • Ma P; College of Pharmacy, Dalian Medical University, Dalian, 116044, China.
  • Zhao Q; The First Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
  • Dai M; The Second Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.
  • Zhu J; The Second Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.
  • Han X; College of Pharmacy, Dalian Medical University, Dalian, 116044, China.
  • Xu H; College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.
  • Chang Q; Pharmacy Department, Dalian Sixth People Hospital of Dalian Medical University, Dalian 116031, China.
  • Zhen Y; College of Pharmacy, Dalian Medical University, Dalian, 116044, China.
Bioconjug Chem ; 32(1): 73-81, 2021 01 20.
Article em En | MEDLINE | ID: mdl-33393280
Multidrug resistance (MDR) is the main obstacle in cancer chemotherapy. ATP-binding cassette (ABC) transporters can transport a wide range of antitumor drugs out of cells, which is the most common reason in the development of resistance to drugs. Currently, various therapeutic strategies are used to reverse MDR, among which CRISPR/Cas9 gene editing technique is expected to be an effective way. Here, we reviewed the research progress of reversing ABC-mediated drug resistance by CRISPR/Cas9 system.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência a Múltiplos Medicamentos / Transportadores de Cassetes de Ligação de ATP / Sistemas CRISPR-Cas Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência a Múltiplos Medicamentos / Transportadores de Cassetes de Ligação de ATP / Sistemas CRISPR-Cas Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China